Novo Nordisk has stopped two trials of a drug that aims to tame inflammation as a way to improve cardiovascular health, another blow for the approach.
STAT
@statnews
Reporting from the frontiers of health & medicine.
Sign up for any of our newsletters here: statnews.com/signup
